About the Company
Tempus AI, Inc. (formerly Tempus Labs) is an American health technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. It was established by Lefkofsky soon after his wife was diagnosed with breast cancer. Tempus uses data and artificial intelligence (AI) to create precision medicine services, including diagnostics, for oncology, cardiology, radiology, and depression. The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM."
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Tempus AI, Inc.
Mixed options sentiment in tempus AI Inc Class A with shares up 3.58%
Mixed options sentiment in tempus AI Inc Class A (TEM), with shares up $2.56, or 3.58%, near $74.15. Options volume running well above average ...
Tempus AI Inc (TEM) Q2 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Advances
Tempus AI Inc (TEM) reports an 89.6% revenue surge and strategic financial improvements, despite ongoing challenges in ...
Tempus AI Raises Outlook, CEO Cites Faster-Than-Expected Growth And Improved Margins
Tempus AI Inc. (NASDAQ:TEM) reported second-quarter financial results Friday. The AI-focused precision medicine and patient ...
Tempus AI, Inc. (NASDAQ:TEM) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Call Transcript August 8, 2025 Tempus AI, Inc. beats earnings expectations. Reported EPS is $-0.22, expectations were $-0.23. Operator: Thank you for standing by, and welcome to ...
Tempus AI, Inc. (NASDAQ:TEM) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Tempus AI, Inc. (NASDAQ:TEM) investors will be delighted, with the company turning in some strong numbers with its latest results. Results overall were solid, with revenues arriving 5.7% better than ...
Tempus AI: A Good Story At A Steep Price - Hold Until It Grows Into It
Tempus AI offers a strong business model with AI-driven genomic data, resilient demand, and significant growth prospects. Click here to read why TEM is a Hold.
Tempus AI, Inc. (TEM) Opinions on Raised 2025 Financial Outlook
Recent discussions on X about Tempus AI, Inc. (TEM) have been buzzing with reactions to the company's latest financial outlook and market movements. Many users have highlighted the firm's raised ...
Tempus AI (TEM) Secures FDA Clearance for AI-Powered Heart Monitoring Software
It marks the second time Tempus AI has received FDA clearance for a cardiovascular product suite.
TEMPUS AI SHAREHOLDER ALERT: CLAIMSFILER REMINDS ... - Morningstar
TEMPUS AI SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Tempus AI, Inc. - TEM PR Newswire ...
Tempus AI, Inc. (TEM) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Conference Call August 8, 2025 8:00 PM ETCompany ParticipantsElizabeth Krutoholow - Vice President of ...
Similar Companies
Loading the latest forecasts...